Meningococcal carriage among Hajj pilgrims, risk factors for carriage and records of vaccination: a study of pilgrims to Mecca.


Journal

Tropical medicine & international health : TM & IH
ISSN: 1365-3156
Titre abrégé: Trop Med Int Health
Pays: England
ID NLM: 9610576

Informations de publication

Date de publication:
04 2021
Historique:
pubmed: 9 1 2021
medline: 31 7 2021
entrez: 8 1 2021
Statut: ppublish

Résumé

The Saudi government requires that all pilgrims receive a quadrivalent meningococcal vaccine at least 10 days before the Hajj. We conducted a study to determine the uptake of meningococcal vaccine and antibiotic use. We also investigated risk factors of meningococcal carriage and carriage of Neisseria meningitidis pathogenic serogroups A, C, W and Y. A cross-sectional oropharyngeal carriage survey was conducted in 2973 Hajj pilgrims in September 2017. A real-time polymerase chain reaction (rt-PCR) assay was used to identify N. meningitidis from the oropharyngeal swabs. A questionnaire investigated potential risk factors for carriage of N. meningitidis. Two thousand two hundred forty nine oropharyngeal swabs were obtained. The overall prevalence of carriage of N. meningitidis was 4.6% (95% CI: 3.4%-6%). Carriage of pathogenic serogroups was not associated significantly with any of the meningococcal risk factors evaluated. 77% of pilgrims were vaccinated but 22.58 % said they were carrying unofficial vaccination cards. Carriage of serogroups A, C, W and Y was not significantly associated with any of the risk factors investigated. Almost a quarter of pilgrims were unlikely to have been vaccinated, highlighting a need to strengthen compliance with the current policy of vaccination to prevent meningococcal disease outbreaks during and after the Hajj.

Identifiants

pubmed: 33415766
doi: 10.1111/tmi.13546
pmc: PMC8049039
doi:

Substances chimiques

Anti-Bacterial Agents 0
Meningococcal Vaccines 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

453-461

Subventions

Organisme : Royal Embassy of Saudi Arabia Cultural Bureau in London, United Kingdom
Organisme : KAUST faculty baseline
ID : BAS/1/1020-01-01

Informations de copyright

© 2021 The Authors Tropical Medicine & International Health Published by John Wiley & Sons Ltd.

Références

Expert Rev Vaccines. 2016 Nov;15(11):1393-1407
pubmed: 27158988
Int J Infect Dis. 2016 Jun;47:71-8
pubmed: 26707071
PLoS One. 2011;6(5):e19513
pubmed: 21625480
Lancet. 2015 Mar 21;385(9973):1072-3
pubmed: 25797556
Euro Surveill. 2013 Sep 12;18(37):
pubmed: 24079399
Clin Infect Dis. 2010 Mar 1;50 Suppl 2:S45-53
pubmed: 20144016
FEMS Microbiol Rev. 2007 Jan;31(1):52-63
pubmed: 17233635
Lancet Infect Dis. 2018 Oct;18(10):1088-1096
pubmed: 30120069
Med Princ Pract. 2010;19(4):321-3
pubmed: 20516711
J Med Microbiol. 2005 May;54(Pt 5):463-466
pubmed: 15824424
Clin Microbiol Infect. 2015 Feb;21(2):109-14
pubmed: 25682276
Lancet. 1999 Mar 20;353(9157):941-2
pubmed: 10459897
Pediatr Infect Dis J. 2004 Dec;23(12 Suppl):S274-9
pubmed: 15597069
Lancet. 2016 Apr 23;387(10029):1719
pubmed: 27116275
Infect Dis Ther. 2016 Jun;5(2):89-112
pubmed: 27086142
East Mediterr Health J. 2008 Mar-Apr;14(2):277-82
pubmed: 18561718
N Engl J Med. 2001 May 3;344(18):1378-88
pubmed: 11333996
J Travel Med. 2018 Jan 1;25(1):
pubmed: 30137404
Scand J Infect Dis. 2004;36(4):264-8
pubmed: 15198182
PLoS One. 2015 Jul 06;10(7):e0132140
pubmed: 26147212
Lancet. 2014 Dec 13;384(9960):2123-31
pubmed: 25145775
Vaccine. 2009 Jun 24;27 Suppl 2:B64-70
pubmed: 19464092
Int J Infect Dis. 2014 Nov;28:171-5
pubmed: 25307887
Infect Disord Drug Targets. 2014;14(2):125-32
pubmed: 25019233
PLoS One. 2011;6(6):e20675
pubmed: 21731621
Travel Med Infect Dis. 2019 Mar - Apr;28:52-58
pubmed: 30118860
Vaccine. 2017 Apr 25;35(18):2473-2478
pubmed: 28343777

Auteurs

Abrar Alasmari (A)

Department of Clinical Research, London School of Hygiene & Tropical Medicine, London, UK.

Joanna Houghton (J)

Department of Clinical Research, London School of Hygiene & Tropical Medicine, London, UK.

Brian Greenwood (B)

Department of Disease Control, London School of Hygiene & Tropical Medicine, London, UK.

David Heymann (D)

Chatham House Centre on Global Health Security, London, UK.
Department of Infectious Disease Epidemiology, London School of Hygiene & Tropical Medicine, London, UK.

Phil Edwards (P)

Department of Population Health, London School of Hygiene & Tropical Medicine, London, UK.

Heidi Larson (H)

Department of Infectious Disease Epidemiology, London School of Hygiene & Tropical Medicine, London, UK.
Department of Global Health, Institute for Health Metrics and Evaluation, University of Washington, Seattle, WA, USA.

Abdullah Assiri (A)

Preventive Health, Ministry of Health, Riyadh, Saudi Arabia.

Fathia Ben-Rached (F)

Biological and Environmental Sciences and Engineering Division, King Abdullah University of Science and Technology (KAUST), Thuwal-Jeddah, Saudi Arabia.

Arnab Pain (A)

Biological and Environmental Sciences and Engineering Division, King Abdullah University of Science and Technology (KAUST), Thuwal-Jeddah, Saudi Arabia.
Global Institution for Collaborative Research and Education, Research Center for Zoonosis Control, Hokkaido University, Sapporo, Japan.

Ron Behrens (R)

Department of Clinical Research, London School of Hygiene & Tropical Medicine, London, UK.

Amaya Bustinduy (A)

Department of Clinical Research, London School of Hygiene & Tropical Medicine, London, UK.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH